Immunology & Oncology

Immunology & Oncology May 8, 2023

Noncomformist Helper T Cell Paves the Way for Immune Hypersensitivity Precision Medicine

Identification of Th9 cells’ role in allergy clarifies huge potential for revolutionizing precision medicine in allergy treatment via JAK-STAT pathway targeting.

Immunology & Oncology May 8, 2023

Enoblituzumab Shows Immunotherapeutic Promise in Localized Prostate Cancer

The successful phase 2 trial results of enoblituzumab highlight its potential as an innovative immunotherapeutic agent for localized prostate cancer.

Immunology & Oncology May 4, 2023

Precision Oncotheranostics with TiY Probe for NSCLC

Tumor-initiating cell probe TiY selectively stains and inhibits the growth of cancer stem cells in an NSCLC onco study.

Immunology & Oncology May 1, 2023

Short-Wave Infrared Illumination Transforms Oncosurgery

Short-wave infrared imaging integrated into fluorescence-guided surgery revolutionizes neuroblastoma treatment, improving patient outcomes.

Immunology & Oncology May 1, 2023

Nuclear Medicine Imaging Demystifies Cognition of Onco Patients

Nuclear medicine imaging enhances understanding of cancer patients’ cognitive state before and after therapy, unraveling the intricacies of their condition.

Immunology & Oncology April 13, 2023

Gut Microbiota, Cancer Immunotherapy Booster?

Gut bacteria in tumors release a tryptophan derived substance that improves immune checkpoint inhibitor treatment, according to recent research.

Immunology & Oncology April 10, 2023

Revealing the Hidden World of Single-Cell Secretions with Plasmonic Microwell Arrays

Real-time protein secretion can be observed by nanoplasmonic imaging, a finding that could help with the creation of cancer therapies, vaccines, and other therapeutics.

Immunology & Oncology April 7, 2023

Unveiling the Regulatory Pool of T Follicular Helper Clones in Germinal Centers

New autoimmune disease treatments that specifically target the immune system may be made possible with this latest research.

Immunology & Oncology April 6, 2023

How ChAT+ T Cells are Revolutionizing Our Understanding of Blood Flow and Inflammation!

The recent study by Karolinska Institutet sheds new light on the regulation of blood flow and inflammation by acetylcholine.

Immunology & Oncology March 23, 2023

TransCure bioServices: A New Way to Study AML

In hopes of advancing acute myeloid leukemia (AML) preclinical investigations, TransCure bioServices provides cell line-derived xenograft (CDX) mice models.

Immunology & Oncology March 22, 2023

Creativity at Its Finest: Creative Proteomics’ Cytokine Assay Bags a Win for Immuno-Oncology

Creative Proteomics launches Cancer Cytokines Assay, which can identify multiple cytokine levels in a single sample.

Immunology & Oncology March 10, 2023

Understanding the Cellular Basis of Immunity

The simplest definition of the human immune system can be found in the cells that compose it.

Immunology & Oncology February 15, 2023

Targeting Cancer with Tech and Therapeutics: An MD Anderson-Xilis Collaboration

Under a preclinical joint research, MD Anderson’s capabilities in oncology research and pharmaceutical innovation is combined with Xilis’ MicroOrganoSphere™ technology.

Immunology & Oncology February 13, 2023

Vanquishing Menacing Malignancies, A Never-Ending Takeda Commitment

With decades of leadership in cancer therapeutics and having a diverse and robust pipeline, Takeda Oncology stays true to its commitment of bringing Better Health and a Brighter Future to people worldwide.

Immunology & Oncology January 13, 2023

What Surgery Can’t Finish, CAR T Might

After breast cancer surgery, preclinical research leads up clinical trials for CAR T cell therapy.

Immunology & Oncology December 20, 2022

Myokine Up, Tumor Down: Exercise vs Cancer

High-intensity interval training by advanced prostate cancer patients effects an acute exercise-induced myokine response and a decrease of tumor development in their serum.

Immunology & Oncology November 28, 2022

Counterintuitive Rheology Sheds Light to Novel Cancer Mechanobiology

Research Teams of JHU’s Konstantopoulos and UPF’s Valverde collaborate to shed light on counterintuitive rheology of cancer cells.

Immunology & Oncology November 25, 2022

Tinkering with Tankyrase Ushers a New Era of Pharmacologics

Inner workings of tankyrase uncovered by researchers, opening the door for possibly better and less harmful cancer treatments.

Immunology & Oncology October 29, 2022

Overcoming Immune Checkpoint Inhibitor Resistance

Overcoming treatment resistance to Immune Checkpoint Inhibitors remains a crucial concern as the modality matures in the mainstream